Quality by design · Risk-based · Always improving
Your partner for end-to-end pharmaceutical development
Science, quality and regulatory expertise in one team
We help pharmaceutical, biotech and medical device companies turn scientific innovation into approved, commercially successful products, with tailored development strategies, modern technology and regulatory rigor.
0+
Successful Projects
0+
Countries Served
0%
Regulatory Success
How we work
Every project runs on the PDCA cycle
The same Plan–Do–Check–Act discipline that drives a GMP quality system drives our own work. Nothing is left to chance, and every cycle leaves the result better than the last.
01 / Plan
Risk-based by default
Risk is assessed before it is accepted
We apply ICH Q9(R1) quality risk management to every decision. Hazards are identified, scored, controlled and reviewed until the residual risk is low and documented.
- 1
Identify
Systematically find what could go wrong: process, product, data, supplier.
- 2
Analyze
Score severity and probability of each hazard with a defined scale.
- 3
Evaluate
Compare the score against acceptance criteria agreed up front.
- 4
Control
Reduce the risk with validated controls, CAPA and change control.
- 5
Review & communicate
Accept the residual risk, document it and monitor it in the next cycle.
Core Expertise
Driving innovation from concept to commercialization with unparalleled scientific and strategic depth.
Formulation Science
Advanced drug delivery systems and stability optimization for maximum therapeutic efficacy.
Process Optimization
Scalable manufacturing solutions with quality by design principles to ensure consistency.
Regulatory Strategy
Global compliance expertise from IND to commercial approval, navigating complex pathways.
Technology Transfer
Seamless knowledge translation between development and manufacturing sites.
What we do
Services across the whole product lifecycle
One integrated team from the first formulation to post-market safety. Hover a service to see where it supports your product.
Why Molgenium
Our strategic approach
A partnership model built on precision, innovation and a commitment to your success.
Evidence-based science
Decisions grounded in rigorous science and data, documented so they stand up to regulatory scrutiny.
Tailored to your product
Every engagement is scoped around your modality, development stage and organization.
Technology-enabled
AI-assisted tools and digital workflows that speed up routine work while keeping full traceability.
Responsive and transparent
A named contact, clear reporting and fast answers at every project stage.
An extension of your team
We work inside your processes and alongside your people, sharing your goals.
Clear regulatory roadmaps
Practical roadmaps that turn complex regulatory and market requirements into next steps.
About Molgenium
From laboratory to market, with quality built in
At Molgenium, we empower pharmaceutical companies to thrive at every stage of the drug and device development process. Our multidisciplinary team of experts combines deep scientific knowledge with strategic regulatory insight to overcome challenges and unlock new opportunities.
We are committed to building collaborative partnerships and delivering tailored solutions that accelerate your journey from laboratory to market, ensuring quality, compliance, and commercial success.
- Pharma, biotech and medical device expertise in one team
- GxP-compliant ways of working, documented and traceable
- Continual improvement through PDCA in every engagement
Ready to accelerate your development?
Tell us where your program stands. We'll propose a tailored plan to take it to the next milestone.
- 1
Introductory call
We listen to your product, stage and goals.
- 2
Tailored proposal
Scope, deliverables, timeline and risks, agreed up front.
- 3
Kick-off
A named lead and a clear plan from day one.